A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans
See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…
CertaraJuly 20, 2026
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
CertaraJuly 16, 2026
When to Conduct Hepatic Impairment Studies and When Modeling May be Enough
How to decide if a hepatic impairment study is required, choose the right study design,…
CertaraJuly 13, 2026
Dosimetry for Radiopharmaceutical Therapy: From Measurement to Dose Justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhDJuly 7, 2026
5 Key Principles of Modern PK/PD in 2026
Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…
CertaraJune 30, 2026
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
CertaraJune 26, 2026
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…
Danielle PillsburyJune 23, 2026
